logo
episode-header-image
Mar 2024
13m 58s

The Evolution Of Cancer Treatment

NPR
About this episode
Recently, the US Food and Drug Administration approved a first-of-its-kind cancer therapy to treat aggresive forms of skin cancer. It has us thinking of the long history of cancer. One of the first recorded mentions of cancer appears in an ancient Egyptian text from around 3000 B.C. And although we now know much more about how cancer begins — as a series of mutations in someone's DNA — it's a disease people are still grappling with how to cure cancers today. This episode, cancer epidemiologist Mariana Stern talks about cancer history and treatment today — plus, why some people are more prone to certain cancers and why that might matter for curing them.

Want to hear about advances in medicine? Email the show at shortwave@npr.org.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy
Up next
Yesterday
The science of emotional regulation — and how to do it better
Do you ever feel like your emotions control you instead of you controlling them? Maybe you lash out at someone after a long day at work or indulge to avoid a stressful situation. It’s called emotional dysregulation and don’t worry – we all experience it at some point. Luckily, th ... Show More
12m 29s
Sep 1
What can seashells teach us about the health of our oceans?
Seashells: They're beautiful remnants to carry home from the beach—and so much more! According to environmental journalist Cynthia Barnett, seashells record history more accurately than the humans who first wrote it down. In this episode, we talk about the science of seashells, t ... Show More
13m 10s
Aug 31
Football is here – and so is a new study on CTE
The NFL season begins this week, but America’s favorite sport has been on our minds for other reasons recently. New research released in the journal BMJ reveals that 1 in 4 former NFL players in this sample had CTE, a neurodegenerative brain disease caused by repetitive head inju ... Show More
15m 1s
Recommended Episodes
Feb 2024
Why we need to rethink how we talk about cancer
For over a century, cancer has been classified by areas of the body - lung cancer, breast cancer, skin cancer etc. And yet modern medical research is telling us that the molecular and genetic mechanisms behind cancers are not necessarily tied to parts of the body. Many drugs deve ... Show More
14m 53s
Nov 2025
Liver cancer: discovering the next generation of therapy targets
For decades, the fight against cancer has focused on killing the tumour cell. We treated cancer like an isolated entity that needed to be destroyed – but what if we’ve been looking at the wrong target? In this episode, we delve into the critical insight that cancer is not just a ... Show More
24m 6s
Nov 2019
Ep. 51 – New Cancer Therapies & Targeting Cancer Biology
Join Lebaron (Lee) Agostini and Connor Wander in our FIRST VIDEO episode! This episode is all about Cancer Biology. Lee studies experimental cancer therapies for pancreatic cancer. New cancer therapies called combination or synergystic cancer therapies use multiple drug types to ... Show More
1h 30m
May 2023
A cancer vaccine?
Dr. Vinod Balachandran explains how he and his colleagues successfully treated pancreatic cancer with bespoke mRNA vaccines. Science journalist Charles Graeber says this could be cancer’s “penicillin moment.” This episode was produced by Avishay Artsy, edited by Matt Collette, fa ... Show More
26m 6s
Oct 2025
179. Back to Basics - Metastatic NSCLC feat. EGFR and ALK Driver Mutations
In this episode, Michael and Josh take a dive into the world of driver mutations, looking at two of the most clinically consequential: EGFR and ALK mutations. The work done in these areas has led to treatments that represent incredible advances over chemotherapy. How incredible? ... Show More
24m 44s
Apr 2024
CAR T-Cells and Safety Signals
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400701. 
25m 25s
Jun 2023
Unleashing CRISPR on Cancer
In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who’s now in remission from previously relapsed lymphoblastic leukemia and talks with the investigator who developed the “off-the-shelf” CAR T cells that made her treatment possible. A f ... Show More
52m 50s
Dec 2023
The Biggest Challenge in Medicine with Dr. Linda Malkas
<p>Why have we not found the cure for cancer yet? Neil deGrasse Tyson, Chuck Nice, and Gary O’Reilly explore paradigm shifts in cancer treatment, molecular biology, and a promising new cancer drug AOH1996 with City of Hope cancer researcher Dr. Linda Malkas. </p><p>NOTE: StarTalk ... Show More
48m 10s